Eli Lilly and Co news

   Watch this stock
Showing stories 1 - 10 of about 65   

Articles published

LLY 81.89 -0.05 (-0.06%)
price chart
Earnings Preview: Eli Lilly & Co
On July 11, 2012, Eli Lilly And Co announced negative clinical trial results from study H8Y-MC-HBBM (HBBM) investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of patients suffering an acute exacerbation of schizophrenia.
Eli Lilly schizophrenia drug fails late-stage trial
Eli Lilly and Co said on Wednesday its experimental schizophrenia drug known as mGlu2/3 did not work in a late stage clinical trial.
Netease, Eli Lilly Attract Bearish Options Attention
Today's tickers: LLY, NTES & HIG. LLY - Eli Lilly and Co. - Shares in the world's 10thlargest pharmaceutical company touched a fresh three-year high of $44.27 today and remain in positive territory, up 0.35% at $44.00 as of 11:20 a.m.
Sepsis: Blood Poisoning Kills Thousands, But No Drugs to Help
In 2001 when the U.S. Food and Drug Administration approved Xigris, made by the pharmaceutical company Eli Lilly, hopes were high that it would keep thousands of patients from dying.
Pulled Sepsis Drug Saved Lives, Could Have Worked [Study]  The Inquisitr
Bristol Myers Squibb, AstraZeneca Join Forces in $7B Deal for Amylin
Additionally, BMY will settle Amylin's obligation to Eli Lilly and Co. for another $1.7 billion. Upon closing of the merger, AstraZeneca will come in as a partner on Amylin assets for $3.4 billion, sharing equally in profits and losses of those assets ...
Lilly to develop company-wide social media strategy
Nearly two years after launching its first major foray into the world of social media in the shape of its LillyPad corporate blog, Eli Lilly is developing a company-wide social media strategy. Lilly has so far had strict rules about who can use social ...
$3 Billion in Fines for Illegal Marketing of Paxil, Wellbutrin and Other Drugs
American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA), the Department of Justice announced today.
The Best Diabetes or Insulin Stock Plays? NVO, LLY, SNY, MRK, AMLN, PODD & MNKD
With diabetes on the rise, insulin is a big business with stocks like Novo Nordisk (NYSE: NVO), Eli Lilly & Co. (NYSE: LLY), Sanofi SA (NYSE: SNY), Merck & Co. (NYSE: MRK), Amylin Pharmaceuticals (NASDAQ: AMLN), Insulet Corporation (NASDAQ: PODD) ...
Earnings Preview: Bristol-Myers Squibb Company
On July 7, 2012, Eli Lilly And Co and Bristol-Myers Squibb Co announced that ERBITUX (cetuximab) in combination with the chemotherapy regimen FOLFIRI (irinotecan, 5-fluorouracil, leucovorin) has been granted full approval by the U.S.
Dems grumbling over big raises for Ballard's staff
Indianapolis Mayor Greg Ballard's staff received a collective 18-percent raise this spring following the hiring of a new deputy for education with an annual salary of $120,000.